Literature DB >> 7795149

Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease.

J Eritsland1, H Arnesen, I Seljeflot, P Kierulf.   

Abstract

The long-term effects of fish-oil supplementation on haemostatic parameters and bleeding episodes were investigated in patients undergoing coronary artery bypass surgery. They were investigated before and 9 months after the operation. Following randomization postoperatively, 260 patients received 4 g fish-oil concentrate per day, whereas 251 patients comprised the control group. All patients received either aspirin (300 mg/day) or warfarin (international normalized ratio aimed at 2.5-4.2). Compliance was affirmed by determination of serum phospholipid fatty acids. No excess of bleeding episodes could be attributed to the use of fish oil, given in addition to either aspirin or warfarin. The supplementation of fish oil did not affect the bleeding time or plasma levels of beta-thromboglobulin, whereas an increase in the platelet count after the operation was slightly less pronounced in the fish-oil group. Apart from a small increase in PAI-1 antigen of borderline significance, no long-term effects by fish oil on parameters of coagulation and fibrinolysis were seen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795149     DOI: 10.1097/00001721-199502000-00003

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  23 in total

Review 1.  Omega-3 fatty acids: their beneficial role in cardiovascular health.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2006-06       Impact factor: 3.275

2.  Phase 1 study of the effect of icosapent ethyl on warfarin pharmacokinetic and anticoagulation parameters.

Authors:  Rene A Braeckman; William G Stirtan; Paresh N Soni
Journal:  Clin Drug Investig       Date:  2014-07       Impact factor: 2.859

3.  The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.

Authors:  Ivar A Eide; Trond Jenssen; Anders Hartmann; Lien M Diep; Dag O Dahle; Anna V Reisæter; Kristian S Bjerve; Jeppe H Christensen; Erik B Schmidt; My Svensson
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-10       Impact factor: 8.237

4.  The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design.

Authors:  Dariush Mozaffarian; Roberto Marchioli; Tim Gardner; Paolo Ferrazzi; Patrick O'Gara; Roberto Latini; Peter Libby; Federico Lombardi; Alejandro Macchia; Richard Page; Massimo Santini; Luigi Tavazzi; Gianni Tognoni
Journal:  Am Heart J       Date:  2011-06-12       Impact factor: 4.749

5.  Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.

Authors:  J S Chen; C L Hill; S Lester; C D Ruediger; R Battersby; G Jones; L G Cleland; L M March
Journal:  Osteoporos Int       Date:  2015-12-22       Impact factor: 4.507

Review 6.  Omega-3 fatty acids in the treatment of psychiatric disorders.

Authors:  Malcolm Peet; Caroline Stokes
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.

Authors:  Robert K McNamara
Journal:  J Nutr Intermed Metab       Date:  2016-05-04

8.  Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production.

Authors:  T Wollny; L Aiello; D Di Tommaso; V Bellavia; D Rotilio; M B Donati; G de Gaetano; L Iacoviello
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

9.  Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Authors:  Robert K McNamara; Jeffrey R Strawn
Journal:  PharmaNutrition       Date:  2013-04

10.  Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients.

Authors:  I A Eide; D O Dahle; M Svensson; A Hartmann; A Åsberg; K S Bjerve; J H Christensen; E B Schmidt; M E Lauritsen; K Lund; T Jenssen
Journal:  Eur J Clin Nutr       Date:  2016-03-02       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.